Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

PSA can help diagnose high androgen levels in women.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

Hair loss improved after removing pituitary tumor.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.